Pharma-Bio Serv, Inc.
Pharma-Bio Serv, Inc.
Your view on PBSV
Overview
What the company does, where it operates, and who runs it.
About Pharma-Bio Serv, Inc.
- Industry
- Specialty Business Services
- Sector
- Industrials
- CEO
- Victor Sanchez
- Headquarters
- Pharma-Bio Serv Building, Dorado, PR, US
- Industry
- Specialty Business Services
- Sector
- Industrials
- CEO
- Victor Sanchez
- Headquarters
- Pharma-Bio Serv Building, Dorado, PR, US
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies in Puerto Rico, the United States, Europe, and Brazil.
Its technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Pharma-Bio Serv, Inc., and the rating behind it. PBSV last traded at $0.59; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Pharma-Bio Serv, Inc.. Starting points for Pharma-Bio Serv, Inc.: beta 0.70 — an Specialty Business Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Pharma-Bio Serv, Inc.. Pharma-Bio Serv, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Pharma-Bio Serv, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Pharma-Bio Serv, Inc.. Pharma-Bio Serv, Inc. has reported as a listed company since 2007. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Pharma-Bio Serv, Inc. valued side by side against its closest peers. Pharma-Bio Serv, Inc. is measured against Specialty Business Services peers within the Industrials sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Pharma-Bio Serv, Inc., and how their positions are changing. At a $13.5M market value, institutional positions materially move Pharma-Bio Serv, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Pharma-Bio Serv, Inc. executives and directors. Shares of Pharma-Bio Serv, Inc. have traded between $0.35 and $1.36 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Pharma-Bio Serv, Inc.. Pharma-Bio Serv, Inc. is a $13.5M Industrials company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Pharma-Bio Serv, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Pharma-Bio Serv, Inc.. Coverage tracks Pharma-Bio Serv, Inc. within Specialty Business Services (Industrials). Press releases and market coverage, newest first.